Mettler-Toledo International MTD
$1,666.88 −$38.78 (-2.27%)
Market closed · Nov 20, 8:10 pm ET · Last extended-hours $1,666.88 0.00%
Open$1,707.54
Prev close$1,705.66
Day range$1,664.92 – $1,719.54
Volume143.7K
Market cap$33.15B
P/E (TTM)36.2
Dividend yield–
MTD Stock News
Headlines matching Mettler-Toledo International or the MTD ticker, most recent first.
- Goldman Sachs Maintains Mettler-Toledo International(MTD.US) With Hold Rating, Raises Target Price to $1,510 Positive
- Rothschild & Co Redburn Initiates Mettler-Toledo International(MTD.US) With Sell Rating, Announces Target Price $1,200
- RBC Capital Downgrades Mettler-Toledo International(MTD.US) to Hold Rating, Raises Target Price to $1,515 Mixed
- Mettler-Toledo International(MTD.US) Officer Sells US$3.21 Million in Common Stock
- Morgan Stanley Maintains Mettler-Toledo International(MTD.US) With Hold Rating, Raises Target Price to $1,450 Positive
- Barclays Maintains Mettler-Toledo International(MTD.US) With Buy Rating, Raises Target Price to $1,575 Positive
- Stifel Maintains Mettler-Toledo International(MTD.US) With Buy Rating, Raises Target Price to $1,600 Positive
- Stifel Maintains Mettler-Toledo International(MTD.US) With Buy Rating, Maintains Target Price $1,400
- BofA Securities Maintains Mettler-Toledo International(MTD.US) With Buy Rating
- Jefferies Maintains Mettler-Toledo International(MTD.US) With Buy Rating, Raises Target Price to $1,580 Positive
- Citi Maintains Mettler-Toledo International(MTD.US) With Buy Rating, Maintains Target Price $1,550
- Evercore Maintains Mettler-Toledo International(MTD.US) With Buy Rating, Cuts Target Price to $1,350 Negative
- Stifel Maintains Mettler-Toledo International(MTD.US) With Buy Rating, Cuts Target Price to $1,400 Negative
- Analysts Offer Insights on Healthcare Companies: Mettler-Toledo (MTD) and Neumora Therapeutics, Inc. (NMRA)
- Morgan Stanley Maintains Mettler-Toledo International(MTD.US) With Hold Rating, Cuts Target Price to $1,078.53 Negative
No comments yet — be the first to weigh in on MTD.
Sign in to join the discussion.